Medacta Group SA (MOVE.SW)
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa.
134.00-0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-9.9%
The outlook
Medacta Group SA currently reads as neutral based on buy — 1.6 avg of 5 analysts, below its 50- & 200-day averages, 12% of the way from its 52-week low to high, avg target +34% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 5 analysts
Price trendBelow its 50- & 200-day averages
52-week range12% of the way from its 52-week low to high
Price targetAvg target +34% vs current price
Analyst price target
~12-month · 5 analysts179.30average target+33.8% vs now
Now 134.00
Low 148.85High 195.22
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$2.67B
52-wk high
177.20
52-wk low
128.20
50-day avg
136.69
200-day avg
149.16
Trailing P/E
30.1